Mark E. Bangs

1.2k total citations
33 papers, 924 citations indexed

About

Mark E. Bangs is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Mark E. Bangs has authored 33 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 14 papers in Clinical Psychology and 12 papers in Pharmacology. Recurrent topics in Mark E. Bangs's work include Attention Deficit Hyperactivity Disorder (15 papers), Treatment of Major Depression (12 papers) and Child and Adolescent Psychosocial and Emotional Development (9 papers). Mark E. Bangs is often cited by papers focused on Attention Deficit Hyperactivity Disorder (15 papers), Treatment of Major Depression (12 papers) and Child and Adolescent Psychosocial and Emotional Development (9 papers). Mark E. Bangs collaborates with scholars based in United States, New Zealand and Belgium. Mark E. Bangs's co-authors include Albert J. Allen, Shuyu Zhang, Graham J. Emslie, Apurva Prakash, Beth A. Pangallo, John S. March, Qi Zhang, D. Desaiah, Paula T. Trzepacz and Ling Jin and has published in prestigious journals such as PEDIATRICS, Biological Psychiatry and Pain.

In The Last Decade

Mark E. Bangs

32 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Bangs United States	16	725	292	219	192	113	33	924
Gregory W. Mattingly United States	18	560 0.8×	142 0.5×	207 0.9×	162 0.8×	68 0.6×	63	813
S Martin United Kingdom	14	693 1.0×	202 0.7×	164 0.7×	248 1.3×	81 0.7×	24	1.0k
Haranath Parepally United States	16	986 1.4×	320 1.1×	141 0.6×	107 0.6×	112 1.0×	24	1.2k
Margaretta Nyilas United States	15	1.2k 1.6×	313 1.1×	143 0.7×	427 2.2×	184 1.6×	28	1.4k
Sara Carucci Italy	11	976 1.3×	283 1.0×	490 2.2×	77 0.4×	109 1.0×	37	1.2k
Virginia K. Sutton United States	19	1.4k 1.9×	445 1.5×	426 1.9×	195 1.0×	135 1.2×	35	1.7k
Rupa Iyengar United States	8	346 0.5×	146 0.5×	332 1.5×	117 0.6×	33 0.3×	17	1.2k
Peter N. van Harten Netherlands	26	1.1k 1.5×	184 0.6×	200 0.9×	87 0.5×	97 0.9×	53	1.6k
Jessica Merchán‐Naranjo Spain	20	736 1.0×	214 0.7×	262 1.2×	55 0.3×	175 1.5×	43	1.0k
Utpal Goswami India	13	1.1k 1.5×	269 0.9×	190 0.9×	97 0.5×	94 0.8×	39	1.3k

Countries citing papers authored by Mark E. Bangs

Since Specialization

Citations

This map shows the geographic impact of Mark E. Bangs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Bangs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Bangs more than expected).

Fields of papers citing papers by Mark E. Bangs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Bangs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Bangs. The network helps show where Mark E. Bangs may publish in the future.

Co-authorship network of co-authors of Mark E. Bangs

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Bangs. A scholar is included among the top collaborators of Mark E. Bangs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Bangs. Mark E. Bangs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nery, Emel Serap Monkul, Mark E. Bangs, Peng Liu, Jonna Ahl, & David Pérahia. (2017). Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 27(8). 700–707. 4 indexed citations

Ball, Susan, James M. Martinez, Beth A. Pangallo, et al.. (2016). Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment. The Journal of Clinical Psychiatry. 77(5). 635–642. 7 indexed citations

Ball, Susan, Sarah Atkinson, JonDavid Sparks, et al.. (2015). Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment. Journal of Clinical Psychopharmacology. 35(3). 266–272. 5 indexed citations

Martinez, James M., Tina M. Oakes, JonDavid Sparks, et al.. (2015). Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder. Drugs in Context. 4. 1–10. 1 indexed citations

Bangs, Mark E., Linda Wietecha, Shufang Wang, Andrew Buchanan, & Douglas K. Kelsey. (2014). Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine. Journal of Child and Adolescent Psychopharmacology. 24(8). 426–434. 41 indexed citations

Atkinson, Sarah, Apurva Prakash, Qi Zhang, et al.. (2014). A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology. 24(4). 180–189. 61 indexed citations

Emslie, Graham J., Apurva Prakash, Qi Zhang, et al.. (2014). A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology. 24(4). 170–179. 78 indexed citations

Ahl, Jonna, Mark E. Bangs, Yingkai Cheng, et al.. (2013). The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. Drug Healthcare and Patient Safety. 5. 211–211. 15 indexed citations

Donnelly, Craig L., Mark E. Bangs, Paula T. Trzepacz, et al.. (2009). Safety and Tolerability of Atomoxetine Over 3 to 4 Years in Children and Adolescents With ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. 48(2). 176–185. 48 indexed citations

10.

Bangs, Mark E., Ling Jin, Shuyu Zhang, et al.. (2008). Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder. Drug Safety. 31(4). 345–354. 48 indexed citations

11.

Bangs, Mark E., Sitra Tauscher‐Wisniewski, John Polzer, et al.. (2008). Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine. Journal of the American Academy of Child & Adolescent Psychiatry. 47(2). 209–218. 98 indexed citations

12.

Quintana, Humberto, Mark E. Bangs, Janet L. Ramsey, et al.. (2007). Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder—A preliminary tolerability and efficacy study. Clinical Therapeutics. 29(6). 1168–1177. 28 indexed citations

13.

Wernicke, Joachim, Karen C. Holdridge, Ling Jin, et al.. (2007). Seizure risk in patients with attention‐deficit‐hyperactivity disorder treated with atomoxetine. Developmental Medicine & Child Neurology. 49(7). 498–502. 65 indexed citations

14.

Bangs, Mark E., Graham J. Emslie, Thomas Spencer, et al.. (2007). Efficacy and Safety of Atomoxetine in Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depression. Journal of Child and Adolescent Psychopharmacology. 17(4). 407–419. 77 indexed citations

15.

Polzer, John, Mark E. Bangs, Shuyu Zhang, et al.. (2006). Meta-Analysis of Aggression or Hostility Events in Randomized, Controlled Clinical Trials of Atomoxetine for ADHD. Biological Psychiatry. 61(5). 713–719. 34 indexed citations

16.

Bayer, Timothy, John Coverdale, Elizabeth Chiang, & Mark E. Bangs. (1998). The role of prior pain experience and expectancy in psychologically and physically induced pain. Pain. 74(2). 327–331. 31 indexed citations

17.

Coverdale, John, Timothy Bayer, Elizabeth Chiang, John Thornby, & Mark E. Bangs. (1994). National Survey on Physiciansʼ Attitudes Toward Social and Sexual Contact With Patients. Southern Medical Journal. 87(11). 1067–1071. 10 indexed citations

18.

Bangs, Mark E., Theodore A. Petti, & Mark‐David Janus. (1994). Fluoxetine-Induced Memory Impairment in an Adolescent. Journal of the American Academy of Child & Adolescent Psychiatry. 33(9). 1303–1306. 30 indexed citations

19.

Bayer, Timothy, et al.. (1993). Anxiety in Experimentally Induced Somatoform Symptoms. Psychosomatics. 34(5). 416–423.

20.

Bangs, Mark E.. (1989). Experts in disarray over sick building syndrome--is it 'all in the mind'?. PubMed. 41(6). 183–183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact